These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6188898)

  • 21. Invasive pharmacodynamic characterization of combined ibopamine and calcium blocker therapy for heart failure.
    Munger MA; Nara AR; Pospisil RA; Stoddard GJ; Schleman M
    Pharmacotherapy; 1993; 13(3):218-23. PubMed ID: 8100627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs.
    Marchetti G; Merlo L
    Arzneimittelforschung; 1986 Feb; 36(2A):331-3. PubMed ID: 3707644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodynamic response to ibopamine in acute myocardial infarction.
    Taniguchi H; Iwasaka T; Sugiura T; Takayama Y; Sumimoto T; Onoyama H; Takashima H; Nakamura S; Inada M
    Arzneimittelforschung; 1990 Apr; 40(4):428-31. PubMed ID: 2357243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitored long-term treatment with ibopamine in patients suffering from severe congestive heart failure.
    Avanzini Z; Bellogini GC; Brusoni B; Ciampani N; Dei Cas L; Gazzola U; Maggi GC; Mangiavacchi M; Metra M; Pinca L
    Arzneimittelforschung; 1986 Feb; 36(2A):394-7. PubMed ID: 3707656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
    Lieverse AG; van Veldhuisen DJ; Smit AJ; Zijlstra JG; Meijer S; Reitsma WD; Lie KI; Girbes AR
    J Cardiovasc Pharmacol; 1995 Mar; 25(3):361-7. PubMed ID: 7769799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
    Van Veldhuisen DJ; Crijns HJ; Girbes AR; Tobé TJ; Wiesfeld AC; Lie KI
    Am J Cardiol; 1991 Nov; 68(11):1194-202. PubMed ID: 1683146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure].
    Nakano T; Isaka N; Konishi T; Tekezawa H; Morimoto Y; Kakuta Y; Kodera T; Kanamaru M
    Kokyu To Junkan; 1987 May; 35(5):553-9. PubMed ID: 3112884
    [No Abstract]   [Full Text] [Related]  

  • 29. Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Henwood JM; Todd PA
    Drugs; 1988 Jul; 36(1):11-31. PubMed ID: 3063492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ibopamine in congestive heart failure refractory to digitalis, diuretics, and captopril.
    Marchionni N; Conti A; De Alfieri W; Di Bari M; Ferrucci L; Lombardi A; Moschi G; Vannucci A
    J Clin Pharmacol; 1986 Jan; 26(1):74-7. PubMed ID: 3512618
    [No Abstract]   [Full Text] [Related]  

  • 31. Peripheral hemodynamic effects of ibopamine in patients with congestive heart failure. A placebo-controlled, double-blind study.
    Longhini C; Ansani L; Musacci GF; Aggio S; Baracca E; Toselli T; Ghirardi P
    Cardiovasc Drugs Ther; 1989 Apr; 3(2):199-202. PubMed ID: 2487532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter study on the clinical efficacy of chronic ibopamine administration.
    Dei Cas L; Barilli AC; Metra M; Fracalossi C; Lomanto B; Santambrogio S; Pinca L; Longhini C; Cavicchi E; Maggi GC
    Arzneimittelforschung; 1986 Feb; 36(2A):383-5. PubMed ID: 3707655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term therapy of chronic congestive heart failure with ibopamine: a multicenter trial.
    Rolandi E; Sabino F; Cantoni V; Ghirardi P; Marchetti GV; Cicchetti V
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S93-103. PubMed ID: 2483446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ibopamine on the failing heart at rest and during isometric exercise: a noninvasive study.
    Partanen J; Nieminen MS; Lehto H
    Clin Cardiol; 1988 Jan; 11(1):15-22. PubMed ID: 3349658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamic effects induced by the combined administration of sodium nitroprusside and ibopamine in patients with congestive heart decompensation].
    Dei Cas L; Giunti G; Faggiano P; Fappani A; Ferrari R; La Canna G; Riva S; Zanini R
    Cardiologia; 1985 Mar; 30(3):205-11. PubMed ID: 4064071
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.
    Rajfer SI; Rossen JD; Douglas FL; Goldberg LI; Karrison T
    Circulation; 1986 Apr; 73(4):740-8. PubMed ID: 3948372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodynamic effects and pharmacokinetics of long-term therapy with ibopamine in patients with chronic heart failure.
    Itoh H; Taniguchi K; Tsujibayashi T; Koike A; Sato Y; Nakamura S
    Cardiology; 1992; 80(5-6):356-66. PubMed ID: 1451123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of digoxin, placebo and ibopamine on exercise tolerance and cardiac rhythm of patients with chronic post-infarct left ventricular failure.
    Cadel A; Brusoni B; Pirelli P; Osculati G; Rovati A; Fanciulli R; Carati L; Valagussa F
    Arzneimittelforschung; 1986 Feb; 36(2A):376-9. PubMed ID: 3707653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A survey of 311 patients receiving ibopamine mainly during hospital treatment for severe congestive heart failure.
    Ferrari V; Sher D; Marchetti G
    Arzneimittelforschung; 1986 Feb; 36(2A):398-405. PubMed ID: 3707657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of ibopamine in congestive heart failure.
    van Veldhuisen DJ; Girbes AR; Crijns HJ; Smit AJ; de Graeff PA; Lie KI
    J Auton Pharmacol; 1990; 10 Suppl 1():s115-21. PubMed ID: 1983005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.